The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand for telemedicine-focused online medical and artificial intelligence (AI)-powered technology services. The rising elderly global population is necessitating many healthcare companies that were traditionally not technology-based to provide technology-enabled services to survive in the market. Per a report by Grand ...

Core Insights - Zacks Premium offers tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to help investors select stocks with high potential for market outperformance [2] Zacks Style Scores Overview - The Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5][6] - Each stock receives a rating from A to F based on its characteristics, with A indicating the highest potential for outperformance [2] Value Score - Focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales [3] Growth Score - Evaluates stocks based on projected and historical earnings, sales, and cash flow to identify sustainable growth opportunities [4] Momentum Score - Targets stocks with favorable price trends, utilizing metrics like one-week price change and monthly earnings estimate changes [5] VGM Score - Combines Value, Growth, and Momentum Scores to provide a comprehensive assessment of stocks [6] Zacks Rank Integration - The Zacks Rank is a proprietary model that leverages earnings estimate revisions to guide investment decisions [7] - Stocks rated 1 (Strong Buy) have historically outperformed the S&P 500, averaging a +23.75% annual return since 1988 [7] Stock Selection Strategy - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal returns [9] - Stocks with lower ranks but high Style Scores may still carry risks due to downward earnings outlooks [10] Company Spotlight: Quest Diagnostics (DGX) - Quest Diagnostics provides diagnostic information services to various customers, including hospitals and physicians [11] - Currently rated 3 (Hold) with a VGM Score of A, DGX has a Momentum Style Score of B and has seen a 6.5% increase in shares over the past month [12] - Recent upward revisions in earnings estimates indicate positive momentum, with the Zacks Consensus Estimate for fiscal 2025 rising to $9.74 per share [12][13]

Company Overview - Quest Diagnostics Inc. is headquartered in Secaucus, New Jersey, providing diagnostic information services to a wide range of customers including physicians, hospitals, patients, and consumers [11] - The company serves Independent Delivery Networks (IDN) across the United States through its Professional Lab Services (PLS), which help improve quality, reduce healthcare costs, and focus on core competencies [11] Zacks Rank and Style Scores - Quest Diagnostics has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [12] - The company is particularly appealing to growth investors, with a Growth Style Score of B, forecasting a year-over-year earnings growth of 9% for the current fiscal year [12] - Six analysts have revised their earnings estimates higher in the last 60 days for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.03 to $9.73 per share [12] Investment Potential - Quest Diagnostics has an average earnings surprise of +2.1%, which may indicate a positive outlook for investors [12] - With a strong Zacks Rank and top-tier Growth and VGM Style Scores, Quest Diagnostics is recommended to be on investors' short lists [13]

Company Overview - Quest Diagnostics Inc. is headquartered in Secaucus, New Jersey, providing diagnostic information services to a wide range of customers, including physicians, hospitals, and patients [11] - The company serves Independent Delivery Networks (IDN) across the United States through its Professional Lab Services (PLS), focusing on improving quality and reducing healthcare costs [11] Zacks Rank and Style Scores - Quest Diagnostics has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [12] - The Value Style Score for Quest Diagnostics is B, supported by a forward P/E ratio of 17.35, making it attractive for value investors [12] - The Zacks Consensus Estimate for fiscal 2025 earnings has increased to $9.70 per share, with one analyst revising their estimate upwards in the last 60 days [12] Investment Potential - With a strong Zacks Rank and favorable Value and VGM Style Scores, Quest Diagnostics is recommended for investors' consideration [13]